Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013.
Vincent RibragDavid E AviganDamian J GreenTrisha Wise-DraperJuan G PosadaRavi VijYing ZhuMohammed Z H FarooquiPatricia MarinelloDavid S SiegelPublished in: British journal of haematology (2019)